Welcome to our dedicated page for Accolade SEC filings (Ticker: ACCD), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page is intended to provide access to historical U.S. Securities and Exchange Commission information for Accolade, Inc. (formerly Nasdaq: ACCD), based on what can be inferred from company communications. While specific SEC forms are not listed here, Accolade’s press releases reference filings such as Form 10-Q for quarterly reports and a Form 8-K for certified voting results related to its merger with Transcarent.
From these disclosures, investors can understand that Accolade used Form 10-Q to report its quarterly financial results, including revenue, net loss, and non-GAAP measures such as Adjusted EBITDA and Adjusted Gross Profit. The company also referenced a proxy statement on Schedule 14A in connection with its annual meeting of stockholders and indicated that it would file preliminary and definitive proxy statements related to the proposed acquisition by Transcarent.
Merger-related communications mention that final, certified voting results from the special meeting of stockholders to approve the Transcarent transaction would be provided in a Form 8-K filed with the SEC. The company also noted that investors could access documents related to the proposed acquisition, including proxy materials and other filings, through the SEC’s website.
Following completion of the merger, Accolade became part of a privately held company and its common stock would no longer be listed on Nasdaq or any public market. For that reason, this page serves primarily as a historical reference for Accolade’s period as a public company, when it filed periodic reports, proxy statements, and transaction-related disclosures with the SEC.
On platforms that offer AI-powered analysis, users can typically review summaries of key filings such as annual reports on Form 10-K, quarterly reports on Form 10-Q, and current reports on Form 8-K, along with any available information on corporate actions connected to the Transcarent acquisition.
This Schedule 13G/A discloses that The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC jointly report beneficial ownership of Accolade, Inc. common stock totaling 65 shares. The cover pages show no sole voting or dispositive power, shared voting power of 44 and shared dispositive power of 65, and that the position represents 0.0% of the class and is held at the level of 5 percent or less. The filing includes a signed joint filing agreement authorizing each party to file amendments and an exhibit identifying Goldman Sachs & Co. LLC as a subsidiary broker/dealer and registered investment adviser of the GS Group. Item 10 certification states the holdings are held in the ordinary course of business and not to influence control.